Helps therapy now has equipment that prolong the lives of people infected with the virus and stop others from acquiring it. They range from antiretroviral therapy , to circumcision and campaigns to reduce promiscuity. Coming are gels and pills that drive back infection during intercourse. Also the outlook for an AIDS vaccine is no as bleak since it used to be much longer. On June 5 AIDS first came to public attention, 1981 in a written report on a rare type of pneumonia in five gay men, but scientists now believe the virus entered human beings early in the 20th century. Last year, the world spent $16 billion on the duty of combating AIDS, half which was donated by wealthy countries and charities. A recent projection approximated that, by 2031, global AIDS costs could reach the equivalent of $35 billion a yr.The business is a critical partner in advancing source chain efficiencies and we’re delighted to extend this award to them, said a known member of the LogiPharma Meeting committee. With the pressures of pedigree regulations and increased counterfeiting and diversion, the pharmaceutical sector wants a solution that provides real-time presence and traceability into developing and offer chain data, stated John DiPalo, chief technology officer, Acsis, Inc. We are honored that the industry recognizes our initiatives to improve efficiencies in the source chain.